For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Elysium Health, Inc.

USPTO Granted Patents = 12

CIPO Patents = 1

EPO Patents = 4

Trademarks = 13

Forward Citations = 6

Loading Chart...

Loading Chart...

19 inventors (with patents filed for the assignee):

Eric Marcotulli (10 out of 10 patents)

Ryan Dellinger (8 out of 18 patents)

Daniel Antonio Alminana (7 out of 7 patents)

4. Mark Morris (6 out of 12 patents)

5. Dan Alminana (3 out of 3 patents)

6. Leonard Pershing Guarente (3 out of 3 patents)

7. Santiago Roel Santos (2 out of 2 patents)

8. Paul M Bowen (2 out of 2 patents)

9. José María Estrela Arigüel (1 out of 2 patents)

10. Rajesh Thamatam (1 out of 1 patent)

11. José Enrique De La Rubia Orti (1 out of 1 patent)

12. José Maria Estrela Ariguel (1 out of 1 patent)

13. Rosario Salvador (1 out of 1 patent)

14. Maria Elena Obrador Pla (1 out of 1 patent)

15. José María Estrela ARIGÜEL (0 patent)

12 patents: Sort by Forward Citations

1. 12350283 - Methods and compositions for treating motor neuron diseases (2025-07-08),

2. 12128060 - Nicotinamide riboside for use in treating or preventing liver damage (2024-10-29),

3. 12109206 - Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders (2024-10-08),

4. 12043616 - Crystalline forms of nicotinamide riboside chloride (2024-07-23),

5. 11998561 - Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disorders (2024-06-04),

6. 11730751 - Treating and preventing motor neuron diseases using nicotinamide riboside (2023-08-22),

7. 11629163 - Methods of synthesizing nicotinamide riboside (2023-04-18),

8. 11426398 - Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders (2022-08-30),

9. 11414407 - Crystalline forms of nicotinamide riboside chloride (2022-08-16),

10. 11389468 - Nicotinamide riboside for use in treating or preventing liver damage (2022-07-19),

11. 11260069 - Nicotinamide riboside and pterostilbene compositions and methods for treatment of neurodegenerative disorders (2022-03-01),

12. 11129843 - Treating and preventing kidney damage (2021-09-28),

Elysium Health is a health company that translates advances in science and technology into clinically-validated health products that work. Founded in 2014 by Dr. Leonard Guarente, Eric Marcotulli, and Dan Alminana, Elysium works with world-class scientists to bring cutting-edge research directly to consumers. Their flagship product, Basis, is a daily supplement designed to support cellular health by increasing levels of NAD+.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

12 Patents

#538 in New York, NY

#1,384 in New York

#24,791 in US

#46,692 in the World

New York, NY, United States of America

Elysium Health, Inc.

Forward Citations = 6

19 inventors:

Eric Marcotulli (10 out of 10 patents)

Ryan Dellinger (8 out of 18 patents)

Daniel Antonio Alminana (7 out of 7 patents)

4. Mark Morris (6 out of 12 patents)

5. Dan Alminana (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…